Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751 SL/PS1M146L transgenic mice

American Journal of Pathology

Volumn 167, Issue 1, 2005, Pages 161-173

  Rutten, Bart P F ^a,b   Van Der Kolk, Nicolien M ^a,b   Schafer, Stephanie ^b,c   Van Zandvoort, Marc A M J ^a   Bayer, Thomas A ^b,c   Steinbusch, Harry W M ^a,b   Schmitz, Christoph ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b European Graduate School of Neuroscience   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SYNAPTOPHYSIN;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IMMUNOREACTIVITY; MOUSE; MOUSE STRAIN; MUTANT; NERVE DEGENERATION; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

EID: 21244480573     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62963-X     Document Type: Article

References (82)

1. Cummings JL: Alzheimer's disease. N Engl J Med 2004, 351:56-67
2. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002 298:789-791
3. Morrison JH, Hof PR: Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res 2002, 136:467-486
4. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356
5. Scheff SW, Price DA: Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 2003, 24:1029-1046
6. Small DH, Mok SS, Bornstein JC: Alzheimer's disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci 2001, 2:595-598
7. Davies CA, Mann DM, Sumpter PQ, Yates PO: A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 1987, 78:151-164
8. Hof PR, Morrison JH: The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 2004, 27:607-613
9. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA: Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 2001, 306:116-120
10. Wirths O, Multhaup G, Czech C, Feldmann N, Blanchard V, Tremp G, Beyreuther K, Pradier L, Bayer TA: Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol 2002, 12:275-286
11. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L: Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 2003, 184:247-263
12. Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA: Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol 2004, 164:1495-1502
13. Dickson DW: Building a more perfect beast: aPP transgenic mice with neuronal loss. Am J Pathol 2004, 164:1143-1146
14. Wirths O, Multhaup G, Bayer TA: A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptidev - the first step of a fatal cascade. J Neurochem 2004, 91:513-520
15. Van de Berg WDJ, Blokland A, Schmitz C, Cuello AC, Steinbusch HWM, Blanco CE: Synaptic numbers in striatum and cortex of aged rats following perinatal asphyxia: a stereologic and behavioral correlative analysis. J Chem Neuroanat 2000, 20:71-82
16. Rutten BP, Wirths O, Van de Berg WD, Lichtenthaler SF, Vehoff J, Steinbusch HW, Korr H, Beyreuther K, Multhaup G, Bayer TA, Schmitz C: No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment. Neurobiol Dis 2003, 12:110-120
17. Masliah E, Terry RD, DeTeresa RM, Hansen LA: Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 1989, 103:234-239
18. Wong TP, Campbell PM, Ribeiro-da-Silva A, Cuello AC: Synaptic numbers across cortical laminae and cognitive performance of the rat during ageing. Neuroscience 1998, 84:403-412
19. Smith TD, Adams MM, Gallagher M, Morrison JH, Rapp PR: Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. J Neurosci 2000, 20:6587-6593
20. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L: High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000, 20:4050-4058
21. King DL, Arendash GW: Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res 2002, 926:58-68
22. Borchardt T, Camakaris J, Cappai R, Masters CL, Beyreuther K, Multhaup G: Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem J 1999, 344:461-467
23. van Zandvoort M, Engels W, Douma K, Beckers L, Oude Egbrink M, Daemen M, Slaaf DW: Two-photon microscopy for imaging of the (atherosclerotic) vascular wall: a proof of concept study. J Vasc Res 2004, 41:54-63
24. Franklin KBJ, Paxinos G: The Mouse Brain in Stereotaxic Coordinates. San Diego, Academic Press, 1996
25. Gundersen HJ, Jensen EB: The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987, 147:229-263
26. Schmitz C, Hof PR: Design-based stereology in neuroscience. Neuroscience 2004, 130:813-831
27. Miles RE, Davy PJ: Precise and general conditions for the validity of a comprehensive set of stereological fundamental formulae. J Microsc 1976, 107:211-226
28. Bugiani O, Giaccone G, Verga L, Polio B, Ghetti B, Frangione B, Tagliavini F: Alzheimer patients and Down patients: abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neurosci Lett 1990, 119:56-59
29. Tsai J, Grutzendler J, Duff K, Gan WB: Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 2004, 7:1181-1183
30. Delatour B, Blanchard V, Pradier L, Duyckaerts C: Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiol Dis 2004, 16:41-47
31. Brendza RP, O'Brien C, Simmons K, McKeel DW, Bales KR, Paul SM, Olney JW, Sanes JR, Holtzman DM: PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures. J Comp Neurol 2003, 456:375-383
32. Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E: Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 2001, 66:573-582
33. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T: Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 2000, 157:331-339
34. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997, 94:13287-13292
35. Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, Pradier L, Brion JP: Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiol Dis 2004, 15:47-60
36. Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, Staufenbiel M, Jucker M: Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 1999, 19:8552-8559
37. Lazarov O, Lee M, Peterson DA, Sisodia SS: Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 2002, 22:9785-9793
38. Ribaut-Barassin C, Dupont JL, Haeberle AM, Bombarde G, Huber G, Moussaoui S, Mariani J, Bailly Y: Alzheimer's disease proteins in cerebellar and hippocampal synapses during postnatal development and aging of the rat. Neuroscience 2003, 120:405-423
39. Nicolle MM, Gallagher M, McKinney M: No loss of synaptic proteins in the hippocampus of aged, behaviorally impaired rats. Neurobiol Aging 1999, 20:343-348
40. Calhoun ME, Kurth D, Phinney AL, Long JM, Hengemihle J, Mouton PR, Ingram DK, Jucker M: Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice. Neurobiol Aging 1998, 19:599-606
41. Mucke L, Abraham CR, Masliah E: Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann NY Acad Sci 1996, 777:82-88
42. Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR: Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res 1994, 666:151-167
43. Wong TP, Debeir T, Duff K, Cuello AC: Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J Neurosci 1999, 19:2706-2716
44. Dodart JC, Mathis C, Saura J, Bales KR, Paul SM, Ungerer A: Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice. Neurobiol Dis 2000, 7:71-85
45. Marjaux E, Hartmann D, De Strooper B: Presenilins in memory, Alzheimer's disease, and therapy. Neuron 2004, 42:189-192
46. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S: Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713
47. Koo EH, Kopan R: Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 2004, 10:326-533
48. Chan SL, Furukawa K, Mattson MP: Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med 2002, 2:167-196
49. Mattson MP, Chan SL: Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 2003, 34:385-397
50. Herms J, Schneider I, Dewachter I, Caluwaerts N, Kretzschmar H, Van Leuven F: Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J Biol Chem 2003, 278:2484-2489
51. Blaustein MP, Golovina VA: Structural complexity and functional diversity of endoplasmic reticulum Ca(2+) stores. Trends Neurosci 2001, 24:602-608
52. Mattiasson G, Friberg H, Hansson M, Elmer E, Wieloch T: Flow cytometric analysis of mitochondria from CA1 and CA3 regions of rat hippocampus reveals differences in permeability transition pore activation. J Neurochem 2003, 87:532-544
53. LaFontaine MA, Mattson MP, Butterfield DA: Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease. Neurochem Res 2002, 27:417-421
54. Begley JG, Duan W, Chan S, Duff K, Mattson MP: Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J Neurochem 1999, 72:1030-1039
55. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J: Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 2003, 23:4499-4508
56. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST: Glycogen synthase kinase-3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 2002, 21:281-293
57. Crabtree GR, Olson EN: NFAT signaling: choreographing the social lives of cells. Cell 2002, 109:367-379
58. Kim DY, Ingano LA, Kovacs DM: Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. J Biol Chem 2002, 277:49976-49981
59. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, Li HC, Schutte M, Gordon R, Holstein GR, Martinelli G, Mehta P, Friedrich VL Jr, Robakis NK: Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell 1999, 4:893-902
60. Thinakaran G, Parent AT: Identification of the role of presenilins beyond Alzheimer's disease. Pharmacol Res 2004, 50:411-418
61. Wang R, Dineley KT, Sweatt JD, Zheng H: Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 2004, 126:305-312
62. Janicki SM, Stabler SM, Monteiro MJ: Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging 2000, 21:829-836
63. Van der Kolk N, van de Steeg E, Rutten BPF, Wirths O, Blanchard V, Itier J, Tremp G, Steinbusch HWM, Pradier L, Bayer TA, Schmitz C: Age-related early hippocampal neuron loss in a novel transgenic/knock-in mouse model of AD. Soc Neurosci Abstr 2004, 338:4
64. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular-Abeta and synaptic dysfunction. Neuron 2003, 39:409-421
65. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J: Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999, 155:853-862
66. Walsh DM, Selkoe DJ: Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004, 44:181-193
67. Rowan MJ, Klyubin I, Cullen WK, Anwyl R: Synaptic plasticity in animal models of early Alzheimer's disease. Philos Trans R Soc Lond B Biol Sci 2003, 358:821-828
68. Klein WL, Krafft GA, Finch CE: Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 2001, 24:219-224
69. Wu CC, Chawla F, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE: Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses. Proc Natl Acad Sci USA 2004, 101:7141-7146
70. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, Schmitz C, Tremp G, Bayer TA, Benoit P, Pradier L: Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 2004, 165:1289-1300
71. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK: Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004, 24:3592-3599
72. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ: Microglia, amyloid and dementia in Alzheimer's disease: a correlative study. Neurobiol Aging 2000, 21:39-47
73. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB: In-vivo measurement of microglia in dementia. Lancet 2000, 358:461-467
74. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS: Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 1996, 17:1005-1013
75. Xia W, Zhang J, Kholodenko D, Citron M, Podlisny MB, Teplow DB, Haass C, Seubert P, Koo EH, Selkoe DJ: Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 1997, 272:7977-7982
76. Sisodia SS, St George-Hyslop PH: gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 2002, 3:281-290
77. Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljarvi L, Koivisto E, Riekkinen PJ Sr: Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 1995, 64:375-384
78. Callahan LM, Coleman PD: Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 1995, 16:311-314
79. Callahan LM, Vaules WA, Coleman PD: Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neural 1999, 58:275-287
80. Callahan LM, Vaules WA, Coleman PD: Progressive reduction of synaptophysin message in single neurons in Alzheimer disease. J Neuropathol Exp Neurol 2002, 61:384-395
81. Kril JJ, Patel S, Harding AJ, Halliday GM: Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol 2002, 103:370-376
82. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259